文献速递生殖医学

不育男性精液中的高危型人乳头瘤病毒与精子前向运动力差及精子DNA碎片指数高相关

High-risk human papillomavirus in semen is associated with poor sperm progressive motility and a high sperm DNA fragmentation index in infertile men.
PubMed 文献 · Hum Reprod · 2019-01-01

这项横断面研究分析了729例原发性不育男性,精液HPV总阳性率为15.5%(113/729),高危型HPV阳性率为10.7%(78/729)。高危型HPV阳性男性的精子前向运动力显著更低(P=0.007)、精子DNA碎片指数显著更高(P=0.003),但多变量分析中HPV状态与精子前向运动力和SDF的关联未达统计学显著。

要点

  • 不育男性精液HPV总阳性率为15.5%(113/729),高危型HPV阳性率为10.7%(78/729)。
  • 高危型HPV阳性男性精子前向运动力显著更低(P=0.007),SDF显著更高(P=0.003)。
  • 多变量分析中年龄、FSH和睾丸体积与精子前向运动力显著相关(均P≤0.04),HPV状态未达显著。

核心结论

  • 高危型HPV精液感染与精子前向运动力受损和精子DNA碎片指数升高相关。
  • 作者认为这些观察结果指出在不育男性诊断检查中准确调查精液HPV存在的重要性。

研究设计与样本

  • 横断面研究,纳入729例因原发性夫妇不育寻求医疗帮助的白人欧洲男性。
  • 采用巢式PCR检测精液样本中的HPV-DNA序列,采用精子染色质结构分析(SCSA)测定SDF指数(SDF≥30%定义为病理),精液分析基于2010年世界卫生组织参考标准。

主要发现

  • HPV总阳性率为15.5%(113/729),高危型HPV阳性率为10.7%(78/729),低危型HPV阳性率为4.8%(35/729)。
  • HPV16是最常见型别(22.1%),其次为HPV43(10.6%)、HPV56和HPV42(均为8.8%)。
  • HPV阳性男性较HPV阴性男性精子前向运动力显著更低(P=0.01)、SDF值显著更高(P=0.005)。
  • 高危型HPV阳性男性较高危型HPV阴性男性精子前向运动力显著更低(P=0.007)、SDF值显著更高(P=0.003)。
  • 单变量分析显示高危型HPV阳性与精子前向运动力受损(P=0.002)和SDF值升高(P=0.003)相关。

关键数值与推荐

  • SDF≥30%定义为病理。
  • 多变量分析中年龄、FSH水平和睾丸体积与精子前向运动力受损显著相关(均P≤0.04),BMI、CCI、吸烟习惯和HPV状态未达显著。
  • 多变量分析中仅年龄(P=0.02)和FSH(P=0.01)与SDF显著相关,校正BMI、CCI、睾丸体积、吸烟习惯和HPV状态后。

临床怎么用

  • 作者认为这些观察结果指出在不育男性诊断检查中准确调查精液HPV存在的重要性。

局限性

  • 主要局限性为研究的横断面设计和亚组样本量相对较小。
  • 其他局限性包括缺乏正常生育男性对照组以及缺乏6-12个月后检查精液中HPV清除或持续存在的随访检测。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Does the presence of human papillomavirus (HPV) in semen impact seminal parameters and sperm DNA quality in white European men seeking medical help for primary couple's infertility? SUMMARY ANSWER: HPV seminal infections involving high-risk (HR) genotypes are associated with impaired sperm progressive motility and sperm DNA fragmentation (SDF) values. WHAT IS KNOWN ALREADY: HPV is commonly present in semen samples. However, whether the presence of HPV in semen is actually associated with impaired sperm parameters and SDF values have yet to be elucidated. STUDY DESIGN, SIZE, DURATION: In this cross-sectional study, complete demographic, clinical and laboratory data from 729 infertile men were analysed. PARTICIPANTS/MATERIALS, SETTING, METHODS: Health-significant comorbidities were scored with the Charlson comorbidity index (CCI). Serum hormones and SDF index (measured by the sperm chromatin structure assay [SCSA]) were measured in every patient (SDF ≥30% was defined as pathological). Semen analysis was based on 2010 World Health Organisation reference criteria. Amplification by nested PCR was used to detect HPV-DNA sequences in semen samples. Descriptive statistics and linear regression models were used to test the association between the presence of HPV and clinical and seminal characteristics in the whole cohort. MAIN RESULTS AND THE ROLE OF CHANCE: The overall rate of HPV positivity was 15.5% (113/729). Overall, 78/729 (10.7%) and 35/729 (4.8%) patients had HR HPV+ and low-risk HPV+, respectively. HPV16 was the most prevalent type (22.1%), followed by HPV43 (10.6%), HPV56 and HPV42 (both 8.8%). No differences were found in terms of clinical and hormonal characteristics between patients with or without seminal HPV. Sperm progressive motility was significantly lower (P = 0.01) while SDF values were higher (P = 0.005) in HPV+ men compared to those with no HPV. In particular, HR HPV+ men had lower sperm progressive motility (P = 0.007) and higher SDF values (P = 0.003) than those with a negative HPV test. Univariable analysis showed that HR HPV+ was associated with impaired sperm progressive motility (P = 0.002) and SDF values (P = 0.003). In the multivariable analysis, age, FSH levels and testicular volume were significantly associated with impaired sperm progressive motility (all P ≤ 0.04). Conversely BMI, CCI, smoking habits and HPV status were not. Only age (P = 0.02) and FSH (P = 0.01) were significantly associated with SDF, after accounting for BMI, CCI, testicular volume, smoking habits and HPV status. LIMITATIONS, REASONS FOR CAUTION: Main limitations are the cross-sectional design of our study and the relatively small sample size of the subgroups. Additional limitations are the lack of a control group of normal fertile men and the lack of follow-up testing to check the clearance or the persistence of HPV in semen after a 6-12 months. WIDER IMPLICATIONS OF THE FINDINGS: Overall, these observations point out the importance of an accurate investigation of seminal HPV presence in everyday clinical practice in the diagnostic work-up of infertile men. STUDY FUNDING/COMPETING INTEREST(S): No external funding was used. There are no competing interests.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Boeri L, Capogrosso P, Ventimiglia E, et al. High-risk human papillomavirus in semen is associated with poor sperm progressive motility and a high sperm DNA fragmentation index in infertile men. Hum Reprod. 2019. PMID: 30517657. doi:10.1093/humrep/dey348

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。